A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
Clinical trial NCT05171855 · COMPLETED
Trial details
- NCT number
- NCT05171855
- Sponsor
- Ascendis Pharma Endocrinology Division A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2024-12-23
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.